Research scientist, Koch Institute for Integrative Cancer Research at MIT, USA
Dr. Hu is currently a research scientist in the Koch Institute for Integrative Cancer Research at MIT. His current research focuses on systems biology with 1) high-throughput drug screening on human macrophages for immunotherapy, 2) system biology of lung macrophages and diseases, 3) transcriptional regulation of memory CD8+ T cells. Dr. Hu obtained his PhD at Nanyang Technological University of Singapore in 2009 and then joined in Koch Institute at MIT as postdoc. Prior to his PhD, Guangan awarded his bachelor’s in bioengineering and master’s in molecular cell and biochemistry at Hubei University, China in 2003.
Systems biology, cancer immunotherapy, immunological memory and vaccination, infectious diseases